Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Jun 2026.
- Largest single sale: $4.1M (18,000 shares) of Lam Research on Feb 6, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Gen Digital (GEN) | Director | Mar 2, 2020 | Sep 11, 2026 |
| Lam Research (LRCX) | Director | Nov 8, 2010 | Jun 15, 2026 |
| Vertex Pharmaceuticals (VRTX) | Former Director | Jun 2, 2004 | Jan 30, 2009 |
Also a director at
Lam Research (LRCX), Vertex Pharmaceuticals (VRTX) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 9, 2026, Gen Digital: 9,072 shares granted; 17,644 shares moved between their own holdings (some held indirectly). 1 filing: 1
- Jun 12, 2026, Lam Research: sold 54,500 shares for $20.0M, under a disclosed plan. 1 filing: 1
- Jun 11, 2026, Lam Research: sold 54,500 shares for $19.1M, under a disclosed plan. 1 filing: 1
- Feb 6, 2026, Lam Research: sold 35,000 shares for $7.9M, no plan disclosed. 1 filing: 1
- Nov 7, 2025, Lam Research: 1,635 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.